David V Goeddel

David V Goeddel has an estimated net worth of $723 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., NGM BIOPHARMACEUTICALS INC, CONSTELLATION PHARMACEUTICALS INC, Revolution Medicines, Inc., Gritstone Oncology, Inc., Tenaya Therapeutics, Inc., RAPT Therapeutics, Inc., Nurix Therapeutics, Inc., Arcus Biosciences, Inc., Oric Pharmaceuticals, Inc., eFFECTOR Therapeutics, Inc., and TULARIK INC.

2022 was David V Goeddel's most active year for acquiring shares with 65 total transactions. David V Goeddel's most active month to acquire stocks was the month of April. 2021 was David V Goeddel's most active year for disposing of shares, totalling 67 transactions. David V Goeddel's most active month to dispose stocks was the month of July. 2019 saw David V Goeddel paying a total of $62,225,985.21 for 24,345,787 shares, this is the most they've acquired in one year. In 2020 David V Goeddel cashed out on 22,571,030 shares for a total of $104,799,656.90, their largest year based on trade value.